InsiderTrades

Form 4 for HALO HALOZYME THERAPEUTICS, INC.

Accepted 2026-02-24 00:00:00 ET · period of report 2026-02-20 · accession 0001159036-26-000029 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-02-24 2026-02-20+ HALO LaBrosse Nicole SVP, CFO F - Tax $70.79 -6,484 38.5K -14% -$459.0K
DM 2026-02-24 2026-02-20+ HALO LaBrosse Nicole SVP, CFO M - OptEx $0.00 +12.0K 38.3K +46% $0
DM 2026-02-24 2026-02-20+ HALO LaBrosse Nicole SVP, CFO M - OptEx $0.00 -12.0K 16.0K -43% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-20 F D 2,876 $70.98 35,414 D — — (F1) The reported disposition of 2,876 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
2 Common Common Stock 2026-02-23 F D 3,608 $70.64 38,494 D — — (F2) The reported disposition of 3,608 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
3 Common Common Stock 2026-02-23 M A 6,688 $0.00 42,102 D — —
4 Common Common Stock 2026-02-20 M A 5,332 $0.00 38,290 D — —
5 Derivative Performance Stock Units 2026-02-23 M D 6,688 $0.00 36,357 D $0.00 · — to — 6,688 Common Stock (F3) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
6 Derivative Restricted Stock Units 2026-02-20 M D 5,332 $0.00 15,995 D $0.00 · — to — 5,332 Common Stock (F3) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.